Almotriptan Malate Tablet, Film Coated
Product Images NDC 0093-5260

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Almotriptan Malate (NDC 0093-5260). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 1)

Chemical Structure (Image 1)
Chemical structure of Almotriptan Malate showing the molecular arrangement of its components including the sulfonyl group, indole ring, and malate moiety.*
FDA Label Image

Figure 1 (Image 2)

Figure 1 (Image 2)
A line graph showing the probability over time post dose (0 to 2 hours) for Almotriptan Malate tablet, film-coated. Three lines represent the placebo, Almotriptan 6.25 mg, and Almotriptan 12.5 mg dosages, indicating increasing probability values with higher doses and time post dose.*
FDA Label Image

Figure 2 (Image 3)

Figure 2 (Image 3)
A line graph showing the probability over 24 hours post-dose for placebo, Almotriptan 6.25 mg, and Almotriptan 12.5 mg. The x-axis represents hours post dose, and the y-axis represents probability. Three curves depict increasing probability over time, with Almotriptan 12.5 mg showing the highest probability and placebo the lowest.*
FDA Label Image

Figure 3 (Image 4)

Figure 3 (Image 4)
A line graph showing the estimated probability of response over time in hours post dose for Almotriptan Malate tablets at 6.25 mg and 12.5 mg strengths compared to placebo. The x-axis represents hours post dose (0 to 2 hours), and the y-axis represents the estimated probability of response (0 to 1). Three lines depict response trends for placebo, Almotriptan 6.25 mg, and Almotriptan 12.5 mg.*
FDA Label Image

Image (Image 5)

Image (Image 5)
Packaging label for Almotriptan Malate Tablets 6.25 mg film-coated tablets by Teva Pharmaceuticals USA, Inc. The carton indicates a package size of 6 tablets with instructions for pharmacists to dispense with enclosed patient information. The label includes storage instructions and a barcode along with NDC 0093-5260-18.*
FDA Label Image

Image (Image 6)

Image (Image 6)
Packaging label for Almotriptan Malate Tablets 12.5 mg film-coated tablets by Teva Pharmaceuticals USA, Inc. The carton shows the product name, strength, quantity of 12 tablets, and storage instructions. The label indicates the product is prescription-only and includes barcodes and distribution details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.